BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33863385)

  • 1. Signaling pathways governing breast cancer stem cells behavior.
    Song K; Farzaneh M
    Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer stem cells, EMT and therapeutic targets.
    Kotiyal S; Bhattacharya S
    Biochem Biophys Res Commun; 2014 Oct; 453(1):112-6. PubMed ID: 25261721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer stem cells: Multiple capacities in tumor metastasis.
    Geng SQ; Alexandrou AT; Li JJ
    Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.
    Takebe N; Warren RQ; Ivy SP
    Breast Cancer Res; 2011 Jun; 13(3):211. PubMed ID: 21672282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
    Siddharth S; Das S; Nayak A; Kundu CN
    Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Breast Cancer Stem Cells.
    Zhang L; Chen W; Liu S; Chen C
    Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNAs in breast cancer stem cells.
    Schwarzenbacher D; Balic M; Pichler M
    Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
    Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
    Front Oncol; 2020; 10():452. PubMed ID: 32426267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells.
    Pourmahdi M; Saber A; Rajabi A; Abdolahi S; Ebrahimi P; Safaralizadeh R
    Curr Stem Cell Res Ther; 2021; 16(7):877-887. PubMed ID: 33563177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
    Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
    Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
    Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
    Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
    Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
    Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
    Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
    J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.